IN2015DN00085A - - Google Patents

Download PDF

Info

Publication number
IN2015DN00085A
IN2015DN00085A IN85DEN2015A IN2015DN00085A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A IN 85DEN2015 A IN85DEN2015 A IN 85DEN2015A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A
Authority
IN
India
Prior art keywords
compounds
preparation
general formula
methods
well
Prior art date
Application number
Other languages
English (en)
Inventor
Volker Schulze
Franz Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IN2015DN00085A publication Critical patent/IN2015DN00085A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
IN85DEN2015 2012-07-10 2013-07-03 IN2015DN00085A (hu)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (1)

Publication Number Publication Date
IN2015DN00085A true IN2015DN00085A (hu) 2015-05-29

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
IN85DEN2015 IN2015DN00085A (hu) 2012-07-10 2013-07-03

Country Status (24)

Country Link
US (1) US9388177B2 (hu)
EP (1) EP2872506A1 (hu)
JP (1) JP6238979B2 (hu)
KR (1) KR20150040845A (hu)
CN (1) CN104603136B (hu)
AP (1) AP3778A (hu)
AU (1) AU2013289381A1 (hu)
BR (1) BR112015000308A2 (hu)
CA (1) CA2878481A1 (hu)
CL (1) CL2015000038A1 (hu)
CO (1) CO7160002A2 (hu)
CR (1) CR20150006A (hu)
DO (1) DOP2015000007A (hu)
EA (1) EA027544B1 (hu)
HK (1) HK1206731A1 (hu)
IL (1) IL236265A (hu)
IN (1) IN2015DN00085A (hu)
MX (1) MX2015000348A (hu)
NZ (1) NZ703020A (hu)
PE (1) PE20150354A1 (hu)
PH (1) PH12015500061A1 (hu)
SG (1) SG11201408419QA (hu)
TN (1) TN2015000008A1 (hu)
WO (1) WO2014009219A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160264568A1 (en) * 2013-06-07 2016-09-15 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
CA2914742A1 (en) 2013-06-11 2014-12-18 Bayer Pharma Aktiengesellschaft Handovers with co-operating cells configured to provide coordinated multi-point transmission/reception
AU2014280356A1 (en) * 2013-06-11 2015-12-24 Bayer Pharma Aktiengesellschaft Prodrug derivatives of substituted triazolopyridines
PL3283642T3 (pl) 2015-04-17 2024-04-22 Crossfire Oncology Holding B.V. Biomarkery prognostyczne dla chemioterapii inhibitorem TTK
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003030937A1 (ja) * 2001-10-05 2005-01-20 小野薬品工業株式会社 ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤
US20060074102A1 (en) * 2004-05-14 2006-04-06 Kevin Cusack Kinase inhibitors as therapeutic agents
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
BRPI0516819A (pt) * 2004-10-07 2008-09-23 Warner Lambert Co derivados de triazolopiridina e agentes antibacterianos
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
EP2029605A1 (en) * 2006-06-06 2009-03-04 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
EP2057158B8 (en) 2006-08-30 2015-09-30 Cellzome Limited Triazole derivatives as kinase inhibitors
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
MX2010000716A (es) 2007-07-18 2010-03-26 Novartis Ag Compuestos de heteroarilo biciclicos y su uso como inhibidores de cinasa.
KR20100057650A (ko) 2007-08-23 2010-05-31 아스트라제네카 아베 증식성 질환의 치료를 위한 ｔｔｋ／ｍｐｓ１의 억제제로서 ２-아닐리노푸린-８-온
WO2009027283A1 (en) 2007-08-31 2009-03-05 Merck Serono S.A. Triazolopyridine compounds and their use as ask inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
US8530689B2 (en) * 2008-05-05 2013-09-10 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
WO2009155527A2 (en) * 2008-06-19 2009-12-23 Progenics Pharmaceuticals, Inc. Phosphatidylinositol 3 kinase inhibitors
EA201101188A1 (ru) 2009-02-13 2012-04-30 Фовеа Фармасьютикалз [1,2,4]триазоло[1,5-а]пиридины в качестве ингибиторов киназы
CA2760077A1 (en) 2009-04-29 2010-11-04 Marcus Koppitz Substituted imidazoquinoxalines
TWI500614B (zh) * 2009-06-05 2015-09-21 Cephalon Inc １，２，４－三唑並〔１，５ａ〕吡啶衍生物之製備和用途
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
US9340528B2 (en) 2009-09-04 2016-05-17 Bayer Pharma Aktiengesellschaft Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343295A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343294A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
US20140120087A1 (en) * 2011-04-21 2014-05-01 Bayer Intellectual Property Gmbh Triazolopyridines
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
NZ703020A (en) 2017-08-25
CN104603136B (zh) 2017-06-27
CL2015000038A1 (es) 2015-03-13
MX2015000348A (es) 2015-04-14
JP6238979B2 (ja) 2017-11-29
HK1206731A1 (en) 2016-01-15
BR112015000308A2 (pt) 2017-06-27
JP2015523372A (ja) 2015-08-13
US9388177B2 (en) 2016-07-12
DOP2015000007A (es) 2015-02-15
AU2013289381A1 (en) 2015-01-22
CR20150006A (es) 2015-02-16
IL236265A (en) 2017-07-31
PH12015500061A1 (en) 2015-03-02
EP2872506A1 (en) 2015-05-20
KR20150040845A (ko) 2015-04-15
US20150148542A1 (en) 2015-05-28
WO2014009219A1 (en) 2014-01-16
AP2014008177A0 (en) 2014-12-31
CN104603136A (zh) 2015-05-06
CO7160002A2 (es) 2015-01-15
PE20150354A1 (es) 2015-03-21
EA027544B1 (ru) 2017-08-31
CA2878481A1 (en) 2014-01-16
EA201590116A1 (ru) 2015-07-30
AP3778A (en) 2016-08-31
TN2015000008A1 (en) 2016-06-29
SG11201408419QA (en) 2015-01-29
IL236265A0 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
NZ743274A (en) Substituted tricyclic compounds as fgfr inhibitors
PH12015502839A1 (en) Antiviral compounds
ZA201500316B (en) Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
IL235944A0 (en) β-lactamase inhibitor compounds, preparations containing them, methods for their preparation and their uses
AU2012213775A8 (en) 7-azaindole derivatives
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
MX352881B (es) Metodos y compuestos utiles en la sintesis de antagonistas del receptor de orexina 2.
IN2014MN02598A (hu)
EA201590887A1 (ru) Композиция
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
IN2014DN06104A (hu)
JO3154B1 (ar) عوامل مضادة لـ trpv4
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
GEP201706626B (en) Synthesis of (s)-nifuratel
PH12015500061A1 (en) Method for preparing substituted triazolopyridines
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
GB201107985D0 (en) Process
MX347541B (es) Analogos de acido sialico.
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
IN2014DN10135A (hu)
MX2015005510A (es) Forma salina solida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.